Bacterium-Mimicking Vector with Enhanced Adjuvanticity for Cancer Immunotherapy and Minimized Toxicity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bacterium-Mimicking Vector with Enhanced Adjuvanticity for Cancer Immunotherapy and Minimized Toxicity
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume -, Issue -, Pages 1901437
Publisher
Wiley
Online
2019-06-17
DOI
10.1002/adfm.201901437
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests
- (2017) Eita Sasaki et al. VACCINE
- Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine
- (2016) Wujin Sun et al. BIOMATERIALS
- Vaccine adjuvants as potential cancer immunotherapeutics
- (2016) Burcu Temizoz et al. INTERNATIONAL IMMUNOLOGY
- DNA–inorganic hybrid nanovaccine for cancer immunotherapy
- (2016) Guizhi Zhu et al. Nanoscale
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns
- (2016) Kate H. Gartlan et al. VACCINE
- NIR-Laser-Controlled Drug Release from DOX/IR-780-Loaded Temperature-Sensitive-Liposomes for Chemo-Photothermal Synergistic Tumor Therapy
- (2016) Fei Yan et al. Theranostics
- The cytokine storm of severe influenza and development of immunomodulatory therapy
- (2015) Qiang Liu et al. Cellular & Molecular Immunology
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles
- (2014) Liangran Guo et al. ACS Nano
- Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids
- (2014) Jiaxi Wu et al. Annual Review of Immunology
- Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients
- (2014) Jana Kayserova et al. CLINICAL IMMUNOLOGY
- The Gammaherpesviruses Kaposi's Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus 68 Modulate the Toll-Like Receptor-Induced Proinflammatory Cytokine Response
- (2014) K. A. Bussey et al. JOURNAL OF VIROLOGY
- Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
- (2014) C. Maisonneuve et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
- (2014) Julia Scheiermann et al. VACCINE
- Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime–protein boost HIV-1 vaccine
- (2014) Kimberly Pouliot et al. VACCINE
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
- (2014) A. B. Sharabi et al. Cancer Immunology Research
- The immune-enhancing effect of the Cronobacter sakazakii ES2 phage results in the activation of nuclear factor-κB and dendritic cell maturation via the activation of IL-12p40 in the mouse bone marrow
- (2013) Tae-Woo An et al. IMMUNOLOGY LETTERS
- Toll-Like Receptor 9 in Plasmacytoid Dendritic Cells Fails To Detect Parvoviruses
- (2013) L. M. Mattei et al. JOURNAL OF VIROLOGY
- Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses
- (2013) T. Chirkova et al. JOURNAL OF VIROLOGY
- Synthesis and Enhanced Colloidal Stability of Cationic Gold Nanoparticles using Polyethyleneimine and Carbon Dioxide
- (2013) Fiaz S. Mohammed et al. ACS Sustainable Chemistry & Engineering
- Recognition of lipid A variants by the TLR4-MD-2 receptor complex
- (2013) Nina Maeshima et al. Frontiers in Cellular and Infection Microbiology
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteers
- (2012) Karthik Venkatakrishnan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines
- (2012) Carl R Alving et al. Expert Review of Vaccines
- Induction of Protective Anti-CTL Epitope Responses against HER-2-Positive Breast Cancer Based on Multivalent T7 Phage Nanoparticles
- (2012) Somayeh Pouyanfard et al. PLoS One
- Phase I Study of Heat-Deployed Liposomal Doxorubicin during Radiofrequency Ablation for Hepatic Malignancies
- (2011) Bradford J. Wood et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Nitric oxide donor trans-[RuCl([15]aneN4)NO]2+ as a possible therapeutic approach for Chagas' disease
- (2010) Paulo MM Guedes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
- (2009) Ryan C. Anderson et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
- (2009) D E Spaner et al. LEUKEMIA
- CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans
- (2008) W. N. Haining et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More